Skip to main content

Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation

Publication ,  Conference
Mammarappallil, MD, PhD, J; Moon MD, RE; MacIntyre MD, NR; Foster PhD, WM; Womack MS, SJ; Ainslie MS RT(R)MR, MD; McAdams, MD, HP; Choudury PhD, K ...
Published in: Journal of Lung, Pulmonary & Respiratory Research
December 30, 2020

Rationale: Recent advances in perfluoropropane magnetic resonance imaging of the lung have provided the means to assess pulmonary ventilation and gas distribution throughout the pulmonary airways and acini in a non-invasive manner. Objectives: The increased density of the inhaled PFP/O2 gas mixture generates longer wash-in times compared to wash-out while breathing room air and leads to slight increases in airway resistance (Raw) and respiratory effort by the subject during imaging. As a consequence of these gas-related effects, we sought to evaluate the cardio-respiratory tolerability of the PFP/O2 gas mixtures in our sequential breath-hold imaging protocol in normal subjects and subjects with obstructive lung disease. Methods: Tolerability was determined by evaluation of changes in vital signs (Heart Rate, Systolic and Diastolic Blood Pressure, Respiratory Rate and Temperature (otic)) at 3 time points (screening, pre-imaging and post-imaging) Measurements and Main Results: Assessment of vital signs before and after the administration of perfluoropropane gas mixture by matched pair analysis demonstrated statistically different values for Heart rate (Mean Difference =-2.417 bpm), Systolic BP (Mean Difference=6.95 mmHg), Diastolic BP (Mean Difference=3.86 mmHg) and SpO2 (Mean Difference=0.56%) even though these do not represent physiologically significant differences compared to activities of daily living such as climbing a flight of stairs. Conclusions: Our data demonstrate no negative outcomes in using PFP gas to image pulmonary ventilation. The PFP gas mixture is safe, well tolerated, and provides a three dimensional ‘picture’ (representation) of inhaled gas distribution for subject cohorts of normal and obstructive lung disease.

Duke Scholars

Published In

Journal of Lung, Pulmonary & Respiratory Research

DOI

EISSN

2376-0060

Publication Date

December 30, 2020

Volume

7

Issue

4

Start / End Page

107 / 115

Publisher

MedCrave Group, LLC

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mammarappallil, MD, PhD, J., Moon MD, R. E., MacIntyre MD, N. R., Foster PhD, W. M., Womack MS, S. J., Ainslie MS RT(R)MR, M. D., … Charles PhD, H. C. (2020). Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation. In Journal of Lung, Pulmonary & Respiratory Research (Vol. 7, pp. 107–115). MedCrave Group, LLC. https://doi.org/10.15406/jlprr.2020.07.00239
Mammarappallil, MD, PhD, Joseph, Richard E. Moon MD, Neil R. MacIntyre MD, W Michael Foster PhD, Samantha J. Womack MS, Maureen D. Ainslie MS RT(R)MR, H Page McAdams, MD, Ahmed F. Halaweish PhD, Kingshuk Choudury PhD, and H Cecil Charles PhD. “Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation.” In Journal of Lung, Pulmonary & Respiratory Research, 7:107–15. MedCrave Group, LLC, 2020. https://doi.org/10.15406/jlprr.2020.07.00239.
Mammarappallil, MD, PhD J, Moon MD RE, MacIntyre MD NR, Foster PhD WM, Womack MS SJ, Ainslie MS RT(R)MR MD, et al. Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation. In: Journal of Lung, Pulmonary & Respiratory Research. MedCrave Group, LLC; 2020. p. 107–15.
Mammarappallil, MD, PhD, Joseph, et al. “Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation.” Journal of Lung, Pulmonary & Respiratory Research, vol. 7, no. 4, MedCrave Group, LLC, 2020, pp. 107–15. Crossref, doi:10.15406/jlprr.2020.07.00239.
Mammarappallil, MD, PhD J, Moon MD RE, MacIntyre MD NR, Foster PhD WM, Womack MS SJ, Ainslie MS RT(R)MR MD, McAdams, MD HP, Halaweish PhD AF, Choudury PhD K, Charles PhD HC. Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation. Journal of Lung, Pulmonary & Respiratory Research. MedCrave Group, LLC; 2020. p. 107–115.

Published In

Journal of Lung, Pulmonary & Respiratory Research

DOI

EISSN

2376-0060

Publication Date

December 30, 2020

Volume

7

Issue

4

Start / End Page

107 / 115

Publisher

MedCrave Group, LLC

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 11 Medical and Health Sciences